Natural Product: NPC94248| Natural Product ID | NPC94248 |
|
Common Name
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
| Zeranol |
| IUPAC Name | (7R,11S)-7,15,17-trihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one |
| Synonyms | MK-188; P-1496; Ralabol; Ralgro; THFES (HM); Zeranol |
| Synthetic Gene Cluster | n.a. |
| ChEMBL Identifier | CHEMBL450613 |
| PubChem CID |
2999413 |
| Chemical Classification |
|
The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.
Chemical Representations
| Standard InCHIKey | DWTTZBARDOXEAM-GXTWGEPZSA-N |
| Standard InCHI | InChI=1S/C18H26O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h10-12,14,19-21H,2-9H2,1H3/t12-,14+/m0/s1 |
| SMILES | C[C@H]1CCC[C@@H](CCCCCc2cc(cc(c2C(=O)O1)O)O)O |
  Calculated Properties
  Species Source| Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
|---|---|---|---|---|---|---|---|---|
| NPO27821.1 | Pochonia chlamydosporia | Under-species | n.a. | n.a. | n.a. | n.a. | n.a. |
PMID[12828470] |
| NPO22748 | Neophaeosphaeria quadriseptata | Species | Leptosphaeriaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[16499313] |
| NPO40515 | Chaetomium chiversii | Species | Chaetomiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[16499313] |
| NPO22748 | Neophaeosphaeria quadriseptata | Species | Leptosphaeriaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration| Organism ID | Organism Name | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
|---|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Biological Activity
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT153 | Individual protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 7562.4 | nM | PMID[20934342] |
| NPT153 | Individual protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 11883.2 | nM | PMID[10924160] |
| NPT153 | Individual protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 6968.3 | nM | PMID[21134751] |
| NPT153 | Individual protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 30856.1 | nM | PMID[19654408] |
| NPT152 | Individual protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 43585.4 | nM | PMID[12662097] |
| NPT162 | Individual protein | Heat shock protein beta-1 | Homo sapiens | Potency | n.a. | 62105.2 | nM | PubChem BioAssay data set |
| NPT248 | Individual protein | Estrogen receptor beta | Homo sapiens | EC50 | = | 24.0 | nM | DOI[10.6019/CHEMBL1201861] |
| NPT109 | Individual protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 3981.1 | nM | DrugMatrix in vivo data: Pathology |
| NPT108 | Individual protein | Estrogen receptor alpha | Homo sapiens | Potency | n.a. | 141.3 | nM | PMID[22055204] |
| NPT153 | Individual protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[10775404] |
| NPT106 | Individual protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[17411092] |
| NPT108 | Individual protein | Estrogen receptor alpha | Homo sapiens | Potency | n.a. | 39810.7 | nM | PMID[14695808] |
| NPT154 | Individual protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[19721074] |
| NPT10 | Individual protein | Geminin | Homo sapiens | Potency | n.a. | 9200.0 | nM | PMID[25305333] |
| NPT152 | Individual protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 66824.2 | nM | PubChem BioAssay data set |
| NPT10 | Individual protein | Geminin | Homo sapiens | Potency | n.a. | 18356.4 | nM | PMID[22703109] |
| NPT103 | Individual protein | Nuclear receptor ROR-gamma | Homo sapiens | Potency | n.a. | 42163.2 | nM | PMID[20194693] |
| NPT101 | Individual protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | n.a. | 11220.2 | nM | PMID[12193011] |
| NPT152 | Individual protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 59557.2 | nM | Open TG-GATES in vivo data: Biochemistry |
| NPT108 | Individual protein | Estrogen receptor alpha | Homo sapiens | RBA | = | 9.0 | % | PMID[24708493] |
| NPT248 | Individual protein | Estrogen receptor beta | Homo sapiens | RBA | = | 12.0 | % | PMID[24708493] |
| NPT158 | Individual protein | Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus | EC50 | = | 38400.0 | nM | PMID[18154272] |
| NPT158 | Individual protein | Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus | Efficacy | = | 46.8 | % | PMID[20966043] |
| NPT483 | Individual protein | Prelamin-A/C | Homo sapiens | Potency | = | 3548.1 | nM | PMID[12027764] |
| NPT483 | Individual protein | Prelamin-A/C | Homo sapiens | Potency | = | 79.4 | nM | PMID[19581457] |
| NPT531 | Individual protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 35481.3 | nM | PMID[20934335] |
| NPT540 | Individual protein | Bile acid receptor FXR | Homo sapiens | Potency | n.a. | 39810.7 | nM | PMID[16499313] |
| NPT540 | Individual protein | Bile acid receptor FXR | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[18077425] |
| NPT94 | Individual protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[20795741] |
| NPT54 | Individual protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 7943.3 | nM | PMID[23046382] |
| NPT7 | Individual protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 100.0 | nM | PMID[15916422] |
| NPT93 | Individual protein | Survival motor neuron protein | Homo sapiens | Potency | = | 35481.3 | nM | PMID[25856683] |
| NPT51 | Individual protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 891.3 | nM | PMID[18434163] |
| NPT59 | Individual protein | DNA polymerase beta | Homo sapiens | Potency | = | 79432.8 | nM | PMID[24689881] |
| NPT445 | Individual protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | n.a. | 16136.6 | nM | PMID[16933872] |
| NPT535 | Individual protein | Parathyroid hormone receptor | Homo sapiens | Potency | n.a. | 39810.7 | nM | PMID[12617583] |
| NPT2264 | Protein family | Heat shock protein HSP90 | Homo sapiens | IC50 | = | 2646.2 | nM | PMID[21051535] |
| NPT2264 | Protein family | Heat shock protein HSP90 | Homo sapiens | IC50 | = | 27927.1 | nM | PMID[17850214] |
| NPT539 | Individual protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[26502160] |
| NPT64 | Individual protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 18356.4 | nM | DOI[10.6019/CHEMBL1201861] |
| NPT64 | Individual protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 7307.8 | nM | PMID[21376582] |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | Efficacy | = | 73.7 | % | PMID[20966043] |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | Efficacy | = | 52.1 | % | PMID[20966043] |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | Efficacy | = | 51.5 | % | PMID[20966043] |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | EC50 | = | 23700.0 | nM | PMID[18332176] |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | EC50 | = | 25100.0 | nM | PubChem BioAssay data set |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | EC50 | = | 4000.0 | nM | PMID[18993063] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT83 | Cell line | MCF7 | Homo sapiens | IC50 | > | 50000.0 | nM | PMID[19105653] |
| NPT397 | Cell line | NCI-H460 | Homo sapiens | IC50 | > | 50000.0 | nM | PMID[19105653] |
| NPT395 | Cell line | SF-268 | Homo sapiens | IC50 | > | 50000.0 | nM | DrugMatrix in vivo data: Hematology |
| NPT65 | Cell line | HepG2 | Homo sapiens | Potency | n.a. | 12589.3 | nM | PMID[25920564] |
| NPT189 | Cell line | Vero | Chlorocebus aethiops | IC50 | = | 50000.0 | nM | PMID[24025124] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 11995.5 | nM | PMID[25136754] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 19011.5 | nM | PMID[17417631] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 69078.2 | nM | PMID[12027772] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 61566 | nM | PMID[24582402] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 848.5 | nM | Open TG-GATES in vivo data: Hematology |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 175 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 6907.8 | nM | PMID[24411199] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 54870.7 | nM | PMID[15214779] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 9439.2 | nM | PMID[19029333] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 23710.1 | nM | PMID[17698618] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 54870.7 | nM | PMID[17190444] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 62105.2 | nM | PMID[17665951] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 29849.3 | nM | PMID[25946116] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 54870.7 | nM | PMID[19456120] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 24724.5 | nM | PMID[18391041] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 35018.2 | nM | PMID[19674905] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 69078.2 | nM | PMID[19854051] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 154.6 | nM | PMID[18077425] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 43967.1 | nM | PMID[21816519] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 18833.6 | nM | DOI[10.6019/CHEMBL1201861] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 69078.2 | nM | PMID[20022253] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 21313.8 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 39185.7 | nM | PMID[21733601] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 55351.3 | nM | DOI[10.6019/CHEMBL1201861] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 26603.2 | nM | PMID[25443644] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 27500.5 | nM | PMID[11421735] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 16785.5 | nM | PMID[18809939] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 54870.7 | nM | PMID[23837878] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 43585.4 | nM | PMID[9873511] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 69078.2 | nM | PMID[9873632] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 43967.1 | nM | PMID[23571415] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 47307.9 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 61566 | nM | PMID[19583252] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 18833.6 | nM | DrugMatrix in vitro pharmacology data |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 61566 | nM | PMID[17958396] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 62105.2 | nM | PMID[7506311] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 23710.1 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 43585.4 | nM | PMID[15217273] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 26603.2 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 30856.1 | nM | PMID[23398362] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 26603.2 | nM | PMID[12213077] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 6968.3 | nM | PMID[10579870] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 30856.1 | nM | PMID[8326318] |
| NPT2 | Others | Unspecified | n.a. | Potency | = | 2592.9 | nM | PMID[17696332] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 12589.3 | nM | PMID[11754603] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 8912.5 | nM | PMID[22652254] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 37578.0 | nM | DOI[10.6019/CHEMBL1201861] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 33491.5 | nM | Open TG-GATES in vivo data: Biochemistry |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 29092.9 | nM | PMID[18597527] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 11220.2 | nM | PMID[22472691] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.2 | mg.kg-1 | PMID[11170659] |
Experimental ADME
| Experiment Model | Experiment Tissue | ADME Type | ADME Relation | ADME Value | ADME Unit | Reference |
|---|
Experimental Toxicity
| Experiment Model | Experiment Organism | Toxicity Type | Toxicity Relation | Toxicity Value | Toxicity Unit | Reference |
|---|---|---|---|---|---|---|
| - | Rattus norvegicus | LEL | = | 0.03 | mg/day | ToxVal |
Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria
| Hepatotoxicity | Carcinogenicity | Mutagenicity | Cardiotoxicity | Respiratory Toxicity | Eye Irritation | Endocrine Disruption |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]
  Chemically structural similarityTop-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)
Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
●  The left chart: Distribution of similarity level between NPC94248 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Natural Product ID |
|---|---|---|
| 1.0 | High Similarity | NPC212693 |
| 0.8039 | Intermediate Similarity | NPC70380 |
| 0.7321 | Intermediate Similarity | NPC191835 |
| 0.7091 | Intermediate Similarity | NPC105456 |
| 0.7091 | Intermediate Similarity | NPC139634 |
| 0.6842 | Remote Similarity | NPC608268 |
| 0.5873 | Remote Similarity | NPC261729 |
| 0.5873 | Remote Similarity | NPC485855 |
| 0.5645 | Remote Similarity | NPC609527 |
| 0.5645 | Remote Similarity | NPC610163 |
| 0.5645 | Remote Similarity | NPC611086 |
| 0.5625 | Remote Similarity | NPC51106 |
| 0.5469 | Remote Similarity | NPC472035 |
| 0.5469 | Remote Similarity | NPC609495 |
| 0.5345 | Remote Similarity | NPC609111 |
| 0.5323 | Remote Similarity | NPC1704 |
| 0.5323 | Remote Similarity | NPC67650 |
| 0.5238 | Remote Similarity | NPC53649 |
| 0.5185 | Remote Similarity | NPC219892 |
| 0.5185 | Remote Similarity | NPC235115 |
| 0.5077 | Remote Similarity | NPC764 |
| 0.5077 | Remote Similarity | NPC475974 |
| 0.5077 | Remote Similarity | NPC487444 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC94248 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Drug ID | Developmental Stage |
|---|---|---|---|
| NPD |
  Bioactivity similaritySimilarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.
